The added value of health-related quality of life as a prognostic indicator of overall survival and progression-free survival in glioma patients: a meta-analysis based on individual patient data from randomised controlled trials

M Coomans; L Dirven; NK Aaronson; BG Baumert; Martin van den Bent; A Bottomley; AA Brandes; O Chinot; C Coens; T Gorlia; U Herrlinger; F Keime-Guibert; A Malmstrom; F Martinelli; R Stupp; A Talacchi; M Weller; W Wick; JC Reijneveld; MJB Taphoorn

doi:10.1016/j.ejca.2019.05.012

The added value of health-related quality of life as a prognostic indicator of overall survival and progression-free survival in glioma patients: a meta-analysis based on individual patient data from randomised controlled trials

M Coomans, L Dirven, NK Aaronson, BG Baumert, Martin van den Bent, A Bottomley, AA Brandes, O Chinot, C Coens, T Gorlia, U Herrlinger, F Keime-Guibert, A Malmstrom, F Martinelli, R Stupp, A Talacchi, M Weller, W Wick, JC Reijneveld, MJB Taphoorn

Neurology

Research output: Contribution to journal › Article › Academic › peer-review

31 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	190-198
Number of pages	9
Journal	European Journal of Cancer
Volume	116
DOIs	https://doi.org/10.1016/j.ejca.2019.05.012
Publication status	Published - 2019

Research programs

EMC OR-01

Access to Document

10.1016/j.ejca.2019.05.012

http://hdl.handle.net/1765/118192

Cite this

Coomans, M., Dirven, L., Aaronson, NK., Baumert, BG., van den Bent, M., Bottomley, A., Brandes, AA., Chinot, O., Coens, C., Gorlia, T., Herrlinger, U., Keime-Guibert, F., Malmstrom, A., Martinelli, F., Stupp, R., Talacchi, A., Weller, M., Wick, W., Reijneveld, JC., & Taphoorn, MJB. (2019). The added value of health-related quality of life as a prognostic indicator of overall survival and progression-free survival in glioma patients: a meta-analysis based on individual patient data from randomised controlled trials. European Journal of Cancer, 116, 190-198. https://doi.org/10.1016/j.ejca.2019.05.012

@article{9f370c8ebb4e4e9194fb1124c8cb5fa2,

title = "The added value of health-related quality of life as a prognostic indicator of overall survival and progression-free survival in glioma patients: a meta-analysis based on individual patient data from randomised controlled trials",

author = "M Coomans and L Dirven and NK Aaronson and BG Baumert and {van den Bent}, Martin and A Bottomley and AA Brandes and O Chinot and C Coens and T Gorlia and U Herrlinger and F Keime-Guibert and A Malmstrom and F Martinelli and R Stupp and A Talacchi and M Weller and W Wick and JC Reijneveld and MJB Taphoorn",

year = "2019",

doi = "10.1016/j.ejca.2019.05.012",

language = "Undefined/Unknown",

volume = "116",

pages = "190--198",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd.",

}

Coomans, M, Dirven, L, Aaronson, NK, Baumert, BG, van den Bent, M, Bottomley, A, Brandes, AA, Chinot, O, Coens, C, Gorlia, T, Herrlinger, U, Keime-Guibert, F, Malmstrom, A, Martinelli, F, Stupp, R, Talacchi, A, Weller, M, Wick, W, Reijneveld, JC & Taphoorn, MJB 2019, 'The added value of health-related quality of life as a prognostic indicator of overall survival and progression-free survival in glioma patients: a meta-analysis based on individual patient data from randomised controlled trials', European Journal of Cancer, vol. 116, pp. 190-198. https://doi.org/10.1016/j.ejca.2019.05.012

The added value of health-related quality of life as a prognostic indicator of overall survival and progression-free survival in glioma patients: a meta-analysis based on individual patient data from randomised controlled trials. / Coomans, M; Dirven, L; Aaronson, NK et al.
In: European Journal of Cancer, Vol. 116, 2019, p. 190-198.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - The added value of health-related quality of life as a prognostic indicator of overall survival and progression-free survival in glioma patients: a meta-analysis based on individual patient data from randomised controlled trials

AU - Coomans, M

AU - Dirven, L

AU - Aaronson, NK

AU - Baumert, BG

AU - van den Bent, Martin

AU - Bottomley, A

AU - Brandes, AA

AU - Chinot, O

AU - Coens, C

AU - Gorlia, T

AU - Herrlinger, U

AU - Keime-Guibert, F

AU - Malmstrom, A

AU - Martinelli, F

AU - Stupp, R

AU - Talacchi, A

AU - Weller, M

AU - Wick, W

AU - Reijneveld, JC

AU - Taphoorn, MJB

PY - 2019

Y1 - 2019

U2 - 10.1016/j.ejca.2019.05.012

DO - 10.1016/j.ejca.2019.05.012

M3 - Article

C2 - 31203194

SN - 0959-8049

VL - 116

SP - 190

EP - 198

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -

Coomans M, Dirven L, Aaronson NK, Baumert BG, van den Bent M, Bottomley A et al. The added value of health-related quality of life as a prognostic indicator of overall survival and progression-free survival in glioma patients: a meta-analysis based on individual patient data from randomised controlled trials. European Journal of Cancer. 2019;116:190-198. doi: 10.1016/j.ejca.2019.05.012